Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000711191 | SCV000526048 | benign | not provided | 2021-03-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085465 | SCV000563089 | benign | Developmental and epileptic encephalopathy 94 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711191 | SCV000841522 | benign | not provided | 2018-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318448 | SCV000851109 | likely benign | Inborn genetic diseases | 2016-07-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000711191 | SCV004130962 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | CHD2: BP4, BP7, BS1 |